$ cat ./records/gavi-vaccine-alliance-launched-at-world-economic-forum-annual-mee-2000.txt
GAVI vaccine alliance launched at World Economic Forum Annual Meeting in Davos
[RECORD.TXT] · cat --full
The Global Alliance for Vaccines and Immunization (GAVI) was formally launched at the World Economic Forum Annual Meeting in Davos with a founding pledge of $750 million from the Gates Foundation — the largest single philanthropic commitment to vaccines in history at that time. The launch at Davos brought together WHO, UNICEF, the World Bank, national governments, and pharmaceutical companies under a single funding umbrella, signaling that public-private partnership was the new model for tackling global health. GAVI has since immunized more than one billion children and saved nearly 19 million lives.
Free forever · No ads · Solo developer
If this was worth a read, help make the next entry possible.
Every entry in this archive was researched, verified, and written by one person — for free. No corporate funding. No ad revenue. Just a developer who believes verified history should be accessible to everyone. Your donation directly funds new entries.
Crypto accepted · No subscription required
← Previous
Judge Jackson orders Microsoft broken into two companies — Gates's biggest legal defeat
Next →
Provided $750 million seed funding to create the GAVI vaccine alliance
[CROSS_REFERENCES] · grep --category='Global Health'
Related Accomplishments
January 2026
Gates-backed World Mosquito Program reaches 16 million people protected from dengue via Wolbachia method
The World Mosquito Program — backed in part by the Gates Foundation — announced in January 2026 that its Wolbachia-infected mosquito releases had reached over 16.1 million people across multiple countries, including Colombia, Indonesia, Brazil, Sri Lanka, Fiji, Vanuatu, and Vietnam. Wolbachia-carrying Aedes aegypti mosquitoes — which block dengue, Zika, chikungunya, and yellow fever transmission — had established self-sustaining populations in treated cities without requiring ongoing releases. Gold-standard randomised trials in Indonesia showed a 77% reduction in dengue incidence. The program represented one of the largest and most cost-effective vector control deployments in history.
2025
Gates-Funded Monoclonal Antibody Shows Early Promise as a Single-Shot Malaria Shield
[ARCHIVE_FUNDING] · INDEPENDENT · NO ADS
One developer. >300 verified entries. Zero ads. Forever free.
No sponsors, no paywall, no algorithm. If this archive has been useful to you, reader support is what keeps it running.